"The U.S. Food and Drug Administration today approved Aptiom (eslicarbazepine acetate) as an add-on medication to treat seizures associated with epilepsy.
Epilepsy is a brain disorder caused by abnormal or excessive activity in the brain"...
- Clinician Information:
Dilantin Kapseals Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Dilantin Kapseals (extended phenytoin sodium) is an antiepileptic drug used to control generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and to prevent and treat seizures occurring during or following neurosurgery. This medication is available in generic form. Common side effects include headache, nausea, vomiting, constipation, dizziness, drowsiness, trouble sleeping, or nervousness.
Patients who have received no previous treatment may be started on a dose of one 100-mg Dilantin three times daily and the dosage then adjusted to suit individual requirements. For most adults, the maintenance dosage will be one capsule three to four times a day. Dilantin Kapseals may interact with azapropazone, delavirdine, dofetilide, etravirine, nisoldipine, rilpivirine, colesevelam, molindone, pyridoxine (vitamin B6), sucralfate, sulfa drugs, telithromycin, amiodarone, azole antifungals, cimetidine, antibiotics, estrogens, isoniazid, rifamycins, St. John's wort, other anti-seizure medicines, drugs to treat cancer, steroids, cyclosporine, felodipine, quetiapine, quinidine, theophylline, vitamin D, warfarin, phenothiazines, antidepressants, or hormonal birth control such as pills, patch, or ring. Tell your doctor all medications and supplements you use. Dilantin Kapseals are not recommended for use during pregnancy. It may harm a fetus. Breastfeeding is not recommended while taking Dilantin Kapseals because this drug appears to pass in low concentrations into breast milk. Withdrawal symptoms may occur if you suddenly stop taking this medication.
Our Dilantin Kapseals (extended phenytoin sodium) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Dilantin Kapseals FDA Prescribing Information: Side Effects
Central Nervous System: The most common manifestations encountered with phenytoin therapy are referable to this system and are usually dose-related. These include nystagmus, ataxia, slurred speech, decreased coordination, and mental confusion. Dizziness, insomnia, transient nervousness, motor twitchings, and headaches have also been observed. There have also been rare reports of phenytoin induced dyskinesias, including chorea, dystonia, tremor, and asterixis, similar to those induced by phenothiazine and other neuroleptic drugs.
A predominantly sensory peripheral polyneuropathy has been observed in patients receiving long-term phenytoin therapy.
Integumentary System: Dermatological manifestations sometimes accompanied by fever have included scarlatiniform or morbilliform rashes. A morbilliform rash (measles-like) is the most common; other types of dermatitis are seen more rarely. Other more serious forms which may be fatal have included bullous, exfoliative or purpuric dermatitis, lupus erythematosus, Stevens-Johnson syndrome, and toxic epidermal necrolysis (see PRECAUTIONS section).
Hemopoietic System: Hemopoietic complications, some fatal, have occasionally been reported in association with administration of phenytoin. These have included thrombocytopenia, leukopenia, granulocytopenia, agranulocytosis, and pancytopenia with or without bone marrow suppression. While macrocytosis and megaloblastic anemia have occurred, these conditions usually respond to folic acid therapy. Lymphadenopathy including benign lymph node hyperplasia, pseudolymphoma, lymphoma, and Hodgkin's disease have been reported (see WARNINGS section).
Connective Tissue System: Coarsening of the facial features, enlargement of the lips, gingival hyperplasia, hypertrichosis, and Peyronie's disease.
Immunologic: Hypersensitivity syndrome (which may include, but is not limited to, symptoms such as arthralgias, eosinophilia, fever, liver dysfunction, lymphadenopathy, or rash), systemic lupus erythematosus, periarteritis nodosa and immunoglobulin abnormalities.
Read the entire FDA prescribing information for Dilantin Kapseals (Extended Phenytoin Sodium Capsules) »
Additional Dilantin Kapseals Information
- Dilantin Kapseals Drug Interactions Center: phenytoin sodium extended oral
- Dilantin Kapseals Side Effects Center
- Dilantin Kapseals FDA Approved Prescribing Information including Dosage
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find tips and treatments to control seizures.